SenesTech shareholder Justin LeBeau increased holdings but saw ownership diluted to 4.76% following a 24.6% share count increase, urging the board to halt low-price ATM sales and reduce expenses.
Stock Titan · 2026-11-18 02:26
SenesTech Inc. appointed JoAnna Abrams to its Board of Directors effective November 16, 2026. The appointment expands the board to eight members to leverage her consumer brand and product intelligence
StreetInsider · 2026-11-17 14:00
SenesTech Inc submitted a Form 8K regulatory filing on November 17, indicating potential significant company news relevant to financial markets.
Investing.com India · 2026-11-17 13:00
SenesTech Inc. CEO Michael Edell filed a Form 4 disclosure on September 14, confirming insider activity for the biotech company focused on biopesticides and senolytic therapies.
Investing.com Canada · 2026-11-16 01:58
SenesTech CEO Michael Edell purchased 1,000 shares for $840 on September 14, 2026, increasing ownership to 9,000 shares following strong Q3 revenue growth despite recent stock declines.
Investing.com Canada · 2026-11-15 23:58
SenesTech reported record Q3 2026 revenues of $1.1 million, a 59% year-over-year increase driven by e-commerce growth and subscription customers for its rodent birth control products.
The Globe and Mail · 2026-11-11 05:11
SenesTech reported Q3 2026 revenue of $1.097M, up 59% YoY, while net losses widened to $2.0M. The firm maintained a 72.6% gross margin and raised $1.2M via an ATM offering.
TradingView · 2026-11-11 04:11
SenesTech reported Q3 earnings with an EPS of ($0.36), beating analyst estimates by $0.02, while revenue reached $1.1 million against a consensus of $694.5 thousand.
StreetInsider · 2026-11-10 22:00
SenesTech Inc reported record Q3 2026 revenue of $1.097 million, marking a 59% year-over-year increase. Growth was driven by strong demand for its rodent birth control solutions, Evolve and ContraPest
ACCESS Newswire · 2026-11-10 20:40
SenesTech reported Q3 2026 revenue up 59% to $1.097 million, driven by e-commerce growth, despite widening net losses to $1.956 million while expanding B2B services.
Stock Titan · 2026-11-10 20:40
SenesTech Inc. announced it will release its third-quarter 2026 financial results after market close on November 10, 2026, followed by a conference call to discuss performance.
StreetInsider · 2026-11-04 21:42
SenesTech Inc. has partnered with Walmart Fulfillment Services to distribute its Evolve® rodent birth control products, improving delivery speed and reducing fulfillment costs.
StreetInsider · 2026-11-04 02:26
SenesTech has partnered with Walmart Fulfillment Services to enhance distribution of its Evolve rodent birth control products. The collaboration enables faster shipping and expanded market reach via W
Stock Titan · 2026-11-03 19:40
SenesTech Inc. has integrated its Evolve rodent birth control products into Walmart Fulfillment Services to improve delivery speed and reduce costs, utilizing EPA-designated minimum risk ingredients f
Investing.com · 2026-11-03 15:04
Glenbrook Capital Management, a director and 10% owner of SenesTech, acquired 30,000 shares worth $29,056 in late October, signaling potential confidence despite the stock's 50% year-to-date decline.
Investing.com · 2026-10-31 23:11
Glenbrook Capital Management filed a Form 4 regarding transactions on October 28, coinciding with a 6.93% increase in SenesTech Inc. stock.
Investing.com Nigeria · 2026-10-31 06:21
Ranni Fakhoury disclosed a 5.02% beneficial ownership stake in SenesTech via Schedule 13G filing, holding 272,000 shares as of August 4, 2026.
Stock Titan · 2026-10-31 01:52
Glenbrook Capital Management purchased 30,000 common shares of SenesTech Inc., increasing its indirect holdings to over 2.1 million shares. The firm holds warrants for an additional 180,000 shares, cu
Stock Titan · 2026-10-31 00:52
SenesTech has appointed Sandstrom Partners as a strategic advisor to enhance sales and branding for its Evolve and ContraPest rodent control products across e-commerce and B2B channels.
The Manila Times · 2026-10-28 19:40
SenesTech Inc.'s Evolve rodenticide achieved an 88% reduction in rat activity during a Chicago pilot. Additionally, rodent-related 911 calls decreased by 36% in the deployment area.
WLS 890 AM · 2026-10-28 14:13
SenesTech insiders purchased 300,770 shares worth $234k recently, signaling confidence despite losses. This net buying pattern suggests an optimistic outlook for the company.
Simply Wall Street · 2026-10-28 10:40
Overview of SenesTech Inc financials and analyst estimates on TradingView, covering reported financial data and trends with standard investment disclaimers.
TradingView · 2026-10-27 19:40
Glenbrook Capital Management filed a Form 4 report detailing insider transactions for SenesTech Inc on October 20, as the company's stock rose 5.77%.
Investing.com South Africa · 2026-10-23 10:12
SenesTech Inc reported record Q3 revenue of $1.1 million but faces Nasdaq delisting risks after trading below $1.00 for 30 days, aiming to regain compliance through financial management.
The Manila Times · 2026-10-23 02:41
SenesTech Inc. received a Nasdaq notice for failing to maintain a minimum bid price, with until April 2027 to regain compliance, despite reporting record Q3 revenue growth.
Quiver Quantitative · 2026-10-22 16:40
SenesTech Inc filed a Form 8K on October 22, 2026, resulting in a 6.53% stock price increase. The filing is considered a significant corporate event for the biotechnology firm.
Investing.com Canada · 2026-10-22 12:42
Glenbrook Capital Management acquired a 38.04% stake in SenesTech for $4.33 million and may recommend board changes following an amended Schedule 13D filing.
Stock Titan · 2026-10-19 21:11
Glenbrook Capital Management disclosed a stake exceeding 30% in SenesTech following 40% Q3 revenue growth. The firm cites undervaluation and insider optimism despite ongoing losses.
GuruFocus · 2026-10-19 20:11
Glenbrook Capital Management acquired over a 30% stake in SenesTech, pushing for marketing and capital allocation changes, including equity-based compensation, despite the company's recent 40% top-lin
StreetInsider · 2026-10-19 19:11
Glenbrook Capital Management has acquired over 30% of SenesTech, urging improved market strategy and capital discipline while engaging Sandstrom Partners for branding assistance.
TradingView · 2026-10-19 19:11